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Summary: Cerebrospinal fluid/plasma concentration quotients for immunoglobulin G (I) and albumin (A)
were determined in guinea pigs. Age and sex-dependent influences on these quotients (I/A) were analysed
and compared with the values for human lumbar, cisternal and ventricular cerebrospinal fluid. The rato I/A,
which characterizes the molecular size-dependent selectivity of the blood cerebrospinal fluid barrier function
for proteins, was found to be a constant in a single species, but showed marked interspecies differences.
Spezies-abhängige Variable der Blut-Liquor-Schrankenfunktion für Proteine
Zusammenfassung: Die Liquor/Plasma Konzentrationsquotienten von Immunglobulin G (I) und Albumin
(A) des Meerschweinchens wurden bestimmt. Alters- und Geschlechts-bedingte Einflüsse auf die Quotienten
(I, A), als auch auf das Quotientenverhältnis I/A wurden untersucht und mit den Werten für den mensch-
lichen lumbalen, cisternalen und Ventrikel-Liquor verglichen. Das Verhältnis I/A, das die Molekülgrößen-
abhängige Selektivität der Blut-Liquor-Schrankenfunktion charakterisiert, ist eine Konstante in der einzelnen
Spezies, variiert aber stark von Spezies zu Spezies.
Introduction
The protein concentrations in human cerebrospinal
fluid (CSF) are used for the diagnosis of neurological
diseases, especially the identification of blood CSF
barrier dysfunctions and local immune response in
central nervous System (ref. cited in I.e. (1)). A cor-
responding analysis of the protein concentrations in
CSF of guinea pigs with chronic relapsing experi-
mental allergic encephalomyelitis is of interest, be-
cause this experimentally induced disease is accepted
äs a model for multiple sclerosis in man (2). We
therefore compared the normal CSF protein profile
and normal blood CSF barrier functions in guinea
pig and man. In addition, we compared the selectivi-
ty coefficients äs an expf ession of the molecular size-
dependent discriminatiön of the barrier function,
which is represented by the ratio of the CSF/plasma
concentration gradients of two proteins with differ-
ent hydrodynamic radius (4). In the present work,
this ratio, introduced earlier (ref. in I.e. (l, 4)), was
investigated with respect to its constancy throughout
the whole CSF space, and with respect to sex, age
and species-dependent variations.
Meihods
Sampling of CSF
Anaesthetised strain 13 guinea pigs were punctured for cistcrnal
CSF by an improved method (3). By this percutaneous suboccipi-
tal puncture about 30-330 } CSF were extracted with a suffi-
ciently low artcfactual blood contamination to calculate a correc-
tion.
The red and the white blood cells wcre counted in a Fuchs-Ro-
senthal counting chamber. Cell counting was done whenever CSF
was collectcd, because even a small contamination with blood can
significantly increase the protein concentration, e.g. at a blood:
CSF volume ratio of 0.0005 (erythrocyte count « 2500/ CSF)
the CSF protein concentration is increased by more than 10%.
Blood samples were removed by cardiac puncture, collected in
heparinized tubes and centrifuged to obtain plasma for further
analysis.
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Protein estimations
IgG and albumin in CSF and plasma were determined by a nephe-
lomctric immunochcmical method on a Beckman ICS-Nephe-
lometcr: To 500 μΐ of a polyethylene glycol solution (4 g/l) in
phosphate buffer (0.1 mol/1, pH = 7.0) 20 μΐ antibody solution
and 10 μΐ sample were added, containing about 0.15 μg albumin
or IgG. After onc hour incubation at room temperature light scat-
tering intcnsity was measured in the sample, in a series of calibra-
tion Standards, in a control serum and in several blanks. Corre-
sponding CSF and plasma samples were analysed in the same se-
ries. Standards guinea pig IgG and albumin were from Sigma.
Rabbit anti guinea pig albumin antiserum (lyophilised) was from
Paesel, Frankfurt and goat anti guinea pig IgG antiserum from
Miles. Antibody Solutions were prediluted in the polyethylene
glycol containing phosphate buffer and centrifuged to eliminate
precipitated unstable components.
Correction for blood contamination in CSF
IgG and albumin concentrations in CSF were corrected by the
formula c} = er - (z/v) cp where er represents the albumin or IgG
concentration determined in CSF, cp represents the corresponding
albumin or IgG concentration in plasma of the same animal, z
represents the red blood cell count (^ 7000/μΙ) in CSF and v
represents the erythrocyte count mean value in blood (5 · 106/μΙ
for adult animals).
Results
The immunochemical analysis of IgG and albumin in
plasma and CSF of guinea pigs had a day-to-day pre-
cision (n = 15) with the following coefficients of Va-
riation: CV = 5% (14 mg/1 albumin) and CV = 7%
(22 mg/1 IgG). The corresponding precision in series
(n = 5) was CV = 2.2% (albumin) and CV = 1.3%
(IgG). The CSF protein concentrations were correct-
ed for a possible artefactual blood contamination us-
ing the red blood cell count (RBC). Normal cell
counts in CSF of guinea pigs are O/μΙ and white
blood cells ^ 4/μΙ.
The normal values of the protein concentrations in
plasma of n = 36 adult guinea pigs were
(mean ± CV): Total protein 55 g/l ± 7.7%, albumin
39.6 g/l ±8.6% and IgG 6.8 g/l ±27%. Young
animals (21 days old, n = 15) had lower serum pro-
tein concentrations with 30.5 g/l ± 8.2% (albumin)
and 2.2 g/l ± 16% (IgG). The corresponding CSF
protein concentrations in adult animals (values of
young animals in brackets) were 87 mg/1 ± 16%
(85 mg/1 ± 17%) for albumin, and 12 mg/1 ± 25%
(5.3 mg/1 ± 28%) for IgG.
For several reasons (l, 4) it is advantageous to eval-
uate the CSF protein data by the correlation of
CSF/plasma concentration quotients. In figure l the
IgG CSF/plasma concentration quotient I (I = IgG
(CSF) · lOVlgG (plasma)) is plotted s a function of
the individual blood CSF barrier function character-
ized by the albumin CSF/plasma concentration quo-
tient A (A = albumin (CSF) - 103/albumin (plas-
The regression line (Γ = 0.66 A-l· 0.32) with a
Standard deviation SyX = 0.20 and a correlation coef-
ficient r = 0.80 had an ordinate segment. For bio-
chemical and theoretical reasons (6) the regression
line ought to go thro gh the origin and the mean
values (Ϊ, ) of the group. The correspondingly cor-
rected regression line was used in figure l with
Ϊ = 0.8 . The recalculated Standard deviation of
syx = 0.22 differed littje from the ernpirical value
(s^x). The reference r nge for the total gro p of adult
animals (dashed lines in fig. 1) was constructed with
the corrected regression line ± 2syx and the mean al-
bumin quotient ± 2 SD (2.17 + 0.83),
-i
l2 χ
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Fig. 1. Reference r nge for CSF/plasma concentration quotients
of IgG and albumin from guinea pig strain 13. Cisternal
CSF, n = 26 adult animals (196, 7$); I = IgG
(CSF) · lOVlgG (plasma); A = albumin (CSF) · 103/ U
bumin (plasma). The reference r nge (dashed line) is de-
fined by the regression line .1 =>0.8A ± 2syx with
Syx = 0.22 and the mean albumin quotient with twofold
Standard deviation ( ± 2 SD = 2.17 ± 0.83).
Th s this reference r nge includes 96% of the nor-
mal cases. Values of A>3.0 indicate blood CSF
barrier dysfunctions in adult guinea pigs. But this
value v ries with age and sex of the animals (tab. 1).
In spite of the variations of the albumin quotient
there was no difference in the ratio Ϊ/ in the differ-
ent guinea pig groups (tab. 1). This ratio of the quo-
tients Ϊ/ is also represented by the slope of the re-
gression line in figure l and characterizes the differ-
ences in barrier permeability for different proteins
due to the different size of the protein molecules (4).
In man there is a large Variation in the albumin
CSF/plasma quotient s a consequence of the caud l
to rostral concentration gradient in the CSF space
(tab. 1). In spite of this large Variation in the albumin
quotient there is a constant ratio Ϊ/ in the whole
CSF space: Ϊ/ = 0.43 or 0.39 or 0.38 for lumbar,
cisternal or ventricular CSF resp^ctively (tab. 1).
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Tab. 1. Variations in blood CSF barrier function for proteins in guinea pig and man.
Ä(CV) = mean and coefficient of Variation (%) of the albumin CSF/plasma concentration quotient (A = albumin (CSF) · l O3/
aibumin (plasma)); = mean of IgG CSF/plasma concentration quotient (I = IgG (CSF) · 103/IgG (plasma)). Concentrations
were inserted in the same units for CSF and plasma. /Ä = discrimination ratio for molecular size-dependent permeability
(identical with the mean of the IgG index (8)).
The data were frorn cisternal CSF of n = 26 (19d, 79) adult strain 13 guinea pigs and n = 9 young animals (21 days old). The
values for human ventricular and cisternal CSF were calculated from I.e. (5) and the values for human lumbar CSF stem from I.e.
(1). All human values refcr to adults and are not differentiated for'sex.
A (CV%)
/
Guinea pig
Adults
6
2.0(17)
0.80
Adults
9
2.6 (9)
0.80
Adults
total
2.2(19)
0.80
Young
total
2.9(17)
0.76
Man
Ventricular
CSF
2.0 (30)
0.38
Cisternal
CSF
3.1 (32)
0.39
Lumbar
CSF
4.6 (30)
0.43
This ratio /Ä = 0.43 for man is different from that
found for guinea pig ( /Ä = 0.8).
From these data for guinea pig and man it can be
suggested that the molecular size-dependent dis-
crimination at the barrier expressed by the ratio of
the CSF/plasma concentration quotients of two dif-
ferent proteins is a constant in a single species but
this constant varies from species to species.
Discussion
The albumin CSF/plasma concentration quotient A
is shown to be a function of various parameters like
barrier permeability, CSF flow and CSF drainage (4,
7). The permeability of the blood CSF barrier for a
single protein depends, amongst other factors, on its
invariant molecular size (4) with strong interindivid-
ual variations. This ability of the barrier to discrimi-
nate according to molecular size can be character-
ized by the ratio of two concentration quotients like
I/A. In particular, the ratio I/A is also known äs the
IgG-index (8). This discrimination ratio which refers
to a single pair of quotients is of course different for
different protein pairs, e.g. a2-macroglobulin quo^
tient/albumin quotient = 0.23 in man (1).
In this commtmication we show that the discrimina-
tion ratio I/A in a single species is a constant which
does not depend on age and sex and also rernains
constant for the whole CSF space. But this discrimi-
•nation ratio seems to be a specieWpecific constant.
In the guinea pig with /Ä = 0.8 there is less size-de-
pendent discrimination than in man with a discrimi-
nation constant /Ä = 0.43. A ratio I/A = l would
mean that there is no size-dependent discrimination
at all. This can be observed only in the pathological
case of a blood CSF barrier dysfunction (l, 9),
The fact that the constant is unique for a single spe-
cies has consequences for a valuable general deserip-
tion of the barrier function for proteins. In terms of a
more generalized description of body fluid barriers
(4) our data show that the blood CSF barrier in gui-
nea pig has a smaller selectivity than the blood CSF
barrier in man. But in the same context (4) our data
contradict the Suggestion that the restrictional forces
to a protein at the barrier, expressed äs the total pro-
tein blood/body fluid concentration quotient (4),
correlate generally with the selectivity of the barrier
(4). This Suggestion is in contrast to the data for man
where different protein ratios (Ä in tab. 1) corre-
spond to a constant selectivity; this is even more ap-
parent if the cisternal CSF of guinea pigs is com-
pared with ventricular CSF of man with similar pro-
tein quotients (Ä in tab. 1), but with a selectivity sig-
nificantly different in both species.
An additional argument against a positive correla-
tion between restrictional forces at the barrier and
selectivity is given by the protein quotient ratios in
aqueous humoür, a compartment with flow and
drainage characteristics different from the CSF
space: in spite of an extraordinarily marked sex and
age dependent aqueous humoür/plasma protein con-
centration quotients, a constant selectivity for these
groups was observed.
This constäncy of the I/A ratio in a single species is
the basis of our evaluation graph for the CSF protein
profile (l, 9), which allows the identification of a lo-
cal IgG synthesis in the central nervous System inde-
pendent of the actual variations of barrier permea-
bility or the location or volume of the CSF sample
(1). The species-dependent difference in the dis-
crimination constant has to be taken into account for
comparison of CSF data from guinea pig with experi-
mental allergic encephalomyelitis äs a model (2)
with CSF data from man with multiple sclerosis. For
such a comparison (9) we developed for the guinea
pig a complete evaluation graph in analogy to that
introduced in clinical chemistry for discrimination of
blood CSF barrier dysfunctions and inflammatory
reaetions in the central nervous System of man (1).
J. Clin. Chcm. Clin, Biochem. / Vol. 2l, 1983 / No. 4
202 Reiber and Thiele: Blood cerebrospinal fluid 'barrier
Acknowledgement
A part of this work belongs to the thesis of P. Thiele and was
supported by the SFB 33.
References
1. Reiber, H. (1980) J. Neurol. 224, 89-99.
2. Wisniewski, H. M., Lassmann, H., Brosnan, C. F., Mehta, P.
D., Lidsky, A. A. & Madrid, R. R. (1982) in Recent Adv. Cliri.
Neurol. (Matthews, W. B. & Glaser, G. H., eds.) 3, 95-124,
Churchill, Livingstone.
3. Reiber, H. & Schunck, O. (1983) Lab. Animals 77, 25-27.
4. Felgenhauer, K. (1980) Pflügers Arch. 384, 9-17.
5. Weisner, B. & Bernhardt, W. (1978) J. Neurol. Sei. 37, 205-
214.
6. Reiber, H- (1979) J. Clin. Chem. Clin. Biochem. 77, 587-
591.
7. Bradbury, M. (1979) The concept of a blood-brain barrier,
•pp. 17-37, J. Wiley & sons, N. Y.
8. Link, H. & Tibbling, G. (1977) J. Clin. Lab. Invest, 57, 397-
401.
9. Suckling, A. J., Reiber, H., Kirby, J. A. & Rumsby, M. G.
(1983) J. Neuroimmunol., in press.
Dr. H. Reiber
Neurocherhisches Labor
der Neurologischen Klinik
Robert-Koch-Str. 40
D-3400 Göttingen
J. Clin. Chem. Clin. Biochem. / Vol. 21, 1983 / No. 4
